The more we find out about this drug, the worse it gets. If you are on these meds I hope you’ll do your research and consider natural alternatives like Ostera from Metagenics. Using a bisphosphonate drug–especially when taken for several years increases your risk of esophageal cancer.
Have you ever wondered about those specific instructions that tell bisphosphonate users to drink a full glass of water and not lie down for 30 minutes after taking the drug? If the drug isn’t swallowed properly, it can irritate the esophagus. If that happens too often, it can cause esophagitis–inflammation of the esophagus.
A few years ago, Danish researchers reviewed more than 11,000 medical records and found that patients with esophagitis were significantly more likely to develop esophageal cancer.
Recognizing the importance of this potential link, a team of UK researchers examined medical records for more than 78,000 patients. As reported this past September in the British Medical Journal, the UK team found that extended bisphosphonate use (about five years) nearly DOUBLED the risk of esophageal cancer.
This is pretty horrifying when you consider that more than 20 million people have used Fosamax since it was introduced in the 90s. And that’s just one brand of this very popular class of drugs.
I recommend Ostera and Cal-Apatite. These can be ordered @ www.DrJeffreyTucker.meta-ehealth.com
In the early 80s, few people had even heard of osteoporosis. And it wasn’t until the next decade – 1993 – when the World Health Organization (WHO) created clear definitions of it. This gave firm criteria for doctors to diagnose brittle bones as a disease.
WHO created this guideline: a woman has osteoporosis when her bone mineral density (BMD) is 2.5 deviations below the standard BMD of average healthy young women. The measurement is made by an x-ray exam. Seems pretty straightforward. Women with a T score of -1.0 and -2.5 have osteoporosis.
Except the WHO study was financed by three drug companies. These three companies were the Rorer Foundation, Sandoz, and SmithKline Beecham. The study they funded led to not only defining criteria for diagnosing osteoporosis… But also to establishing it firmly as a marketable disease.
The drug companies stood to benefit greatly if definitions of osteoporosis included large numbers of postmenopausal women. Especially if BMI testing was adopted into routine medical care.
There’s one important point to make here. Women’s bones do become more brittle with age. And hip and thigh fractures are a major cause for concern for women after they hit menopause.
The following year – in 1994 – the WHO study group recommended screenings and interventions. They determined that the “appropriate time” for these tests was menopause. To make sure no one missed it, their recommendation was published in Osteoporosis International. Suddenly, BMD became part of routine care for millions of postmenopausal women. The drug companies were assured that millions would be seeking billions of dollars’ worth of their drugs.
By 1995 Fosamax appeared on the market. The first of the brand new osteoporosis drugs. It was swiftly approved by the FDA. Osteoporosis screenings, treatment, and drugs became part of the American lifestyle. Almost overnight.
But there has never been any proof to show that any of these steps actually help women whatsoever.
What is safe and effective for bone nutrition and osteoporosis prevention? Weight bearing exercise and the supplement Cal Apatite with Magnesium by Metagenics. If you already have osteopenia (bone loss) or osteoporosis then you need Ostera by Metagenics. Order from www.DrJeffreyTucker.meta-ehealth.com
NSAID’s are inexpensive, we have easy access to them, and they do help pain go away. BUT, are they safe?
Answer: Even short term use may increase the risk of gastrointestinal bleeding. Long-term use of prescription NSAIDs prompts well over 100,000 hospitalizations every year due to upper gastrointestinal adverse events. More than 16,500 of those patients die–every year!
One study found that NSAID use after age 60 may increase heart failure risk by 30 percent. And that risk rises sharply in the presence of other heart problems such as high blood pressure or type 2 diabetes.
Another potential side effect is stroke. Researchers out of Denmark (Gentofte University) followed prescription records for two “COX-2 selective” NSAIDs: Celebrex and Vioxx. Also followed: three “non-selective” NSAIDs: naproxen (Aleve), diclofenac (Cataflam), and ibuprofen (Advil, Motrin).
When prescription data was analyzed alongside hospitalization and death registry data, ibuprofen was linked with a 30 percent increased risk of stroke. Ibuprofen, used for a limited time by healthy people appears to significantly increase stroke risk.
Diclofenac may sharply increase stroke risk (more than 85 percent!), but that Aleve did not appear to increase stroke risk much at all. In all five medications, higher doses produced increased stroke risk.
Now you decide – what’s better, the natural anti-inflammtories I prescribes to you or these over the counter meds?